Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of KRYS will rise by +11.62% over the next 2 Weeks and hit $383.34 by Monday, July 6, 2026. In that time frame, KRYS's share price is expected to range between $370.26 and $395.98.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 6, 2026 | 370.26 | 383.34 | 395.98 |
| Jul 3, 2026 | 366.60 | 378.35 | 389.68 |
| Jul 2, 2026 | 368.92 | 379.19 | 389.80 |
| Jul 1, 2026 | 363.34 | 372.87 | 382.52 |
| Jun 30, 2026 | 357.57 | 365.57 | 373.85 |
| Jun 29, 2026 | 355.89 | 363.38 | 370.61 |
| Jun 26, 2026 | 352.23 | 358.39 | 364.69 |
| Jun 25, 2026 | 352.62 | 359.23 | 365.37 |
| Jun 24, 2026 | 346.70 | 352.91 | 359.27 |
| Jun 23, 2026 | 340.09 | 345.61 | 351.51 |
KRYS shares fell -1.33% in Monday, June 22, 2026's trading session, dropping from a previous close of $348.06 to move at $343.43. The stock demonstrated notable intraday movement (see KRYS's key stats for a full breakdown), fluctuating between $341.66 and $356.41, a +4.32% trading range. While recent weeks have seen some volatility, KRYS has managed to secure a +13.81% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 411.61K shares changing hands, 399.65K fewer than the previous session. This amounted to $141.36M in total market activity.
Will KRYS Continue Its Upward Trend?
According to analyst ratings and projections for KRYS, Krystal Biotech, Inc. shares are anticipated to increase by +13.27%, potentially reaching $395.98 per share by July 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for KRYS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 20 positive trading days within the past 30 sessions. Based on the KRYS stock forecast, now is a good time to buy KRYS stock because its current trading price is -10.41% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on KRYS covering social and institutional perspectives.
KRYS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into KRYS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 67.00% to 72.71%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 61.86%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 59.62%, maintains a neutral outlook for the long term. Insights into KRYS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Krystal Biotech Short-Term Forecasts
KRYS Forecast For Next 5 Days
Our algorithm anticipates Krystal Biotech (KRYS) stock could hit $310.71 by Jun 29, 2026. This represents a -9.53% rise from today's price, following a +0.98% change over the past five days.
KRYS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Krystal Biotech, Inc. (KRYS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $325.44, which would mean a -5.24% decrease from the current price of $343.43. Projections for this period range from a high of $352.75 to a low of $299.92.
KRYS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Krystal Biotech's price over the next three months point to a rise. KRYS stock is expected to peak at $369.71 on Sep 17, 2026 after potentially dipping to $324.90 on Aug 06, 2026. On average, KRYS is likely to trade around $346.86 in the coming 90 days.
Krystal Biotech Stock Forecast 2025
Based on our predictive models, Krystal Biotech (KRYS) is expected to trade between $324.90 and $393.33 throughout 2026. This would result in an average price of $355.64, potentially offering investors a +3.56% return from current levels.
Krystal Biotech, Inc. Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, Krystal Biotech, Inc. (KRYS) is positioned to show a strong performance in June 2026. The price is predicted to move between $328.96 and $360.72, settling at an average of $344.86. This could translate to a +0.42% gain.
July 2026
Based on current market signals, Krystal Biotech, Inc. is projected to trend july 2026. We forecast a trading range from $327.83 to $361.38, with a likely average price of $344.63. Investors could expect a potential return of +0.35%.
August 2026
Our predictive algorithms indicate Krystal Biotech, Inc. stock may see a shift in August 2026. The expected range spans $324.90–$360.40, with an average target of $344.07. This represents a positive outlook and a possible gain of +0.19%.
September 2026
Analyzing established trends, Krystal Biotech, Inc. looks set to move in September 2026. Projections place the stock between $337.16 and $370.66, averaging around $354.57. This suggests a +3.24% gain from current levels.
October 2026
Market indicators suggest Krystal Biotech, Inc. could experience notable changes during October 2026. Prices could fluctuate within $347.16 to $377.73, with a midpoint forecast of $361.78. The stock might deliver a +5.34% gain.
November 2026
Forecasting for November 2026, models estimate that Krystal Biotech, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $348.56 and $393.33, averaging $368.44. This signals a positive trajectory with potential returns around +7.28%.
December 2026
According to our latest forecast models, Krystal Biotech, Inc. (KRYS) is positioned to show a strong performance in December 2026. The price is predicted to move between $346.93 and $379.37, settling at an average of $363.50. This could translate to a +5.84% gain.
January 2027
Based on current market signals, Krystal Biotech, Inc. is projected to trend january 2027. We forecast a trading range from $344.98 to $382.55, with a likely average price of $364.14. Investors could expect a potential return of +6.03%.
February 2027
Our predictive algorithms indicate Krystal Biotech, Inc. stock may see a shift in February 2027. The expected range spans $357.47–$390.28, with an average target of $374.29. This represents a positive outlook and a possible gain of +8.99%.
March 2027
Analyzing established trends, Krystal Biotech, Inc. looks set to move in March 2027. Projections place the stock between $365.79 and $396.66, averaging around $381.24. This suggests a +11.01% gain from current levels.
April 2027
Market indicators suggest Krystal Biotech, Inc. could experience notable changes during April 2027. Prices could fluctuate within $368.77 to $410.66, with a midpoint forecast of $387.58. The stock might deliver a +12.86% gain.
May 2027
Forecasting for May 2027, models estimate that Krystal Biotech, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $366.60 and $398.23, averaging $382.69. This signals a positive trajectory with potential returns around +11.43%.
June 2027
According to our latest forecast models, Krystal Biotech, Inc. (KRYS) is positioned to show a strong performance in June 2027. The price is predicted to move between $366.08 and $400.33, settling at an average of $382.46. This could translate to a +11.36% gain.
KRYS's history of dividends and stock splits also plays a role in long-term investor confidence.

